Jill Makin

Company: Touchlight

Job title: Chief Scientific Officer

Bio:

Jill has worked for Touchlight since 2012, driving the transformation of the dbDNA technology from discovery into a robust and scalable DNA manufacturing platform, into GMP production.

In her current role, she oversees a group whose focus is to continually improve our manufacturing offering (transferring these improvements into our CDMO) and expanding the utility of dbDNA, building on our strong IP portfolio. Jill also provides development oversight to products arising from our product discovery team and heading towards clinic.

Prior to Touchlight, Jill worked in senior R&D roles, and as a consultant, in the biotech/vaccine industry, including positions at Emergent BioSolutions, Celltech-Medeva and a number of start-ups. Jill holds a PhD in influenza research.

Seminars:

Simply scaling DNA from R&D to GMP with dbDNA™ (doggybone DNA) technology 11:50 am

In this session you will learn: How to eliminate historical plasmid transition barriers from R&D to GMP with cell-free DNA How the proven dbDNA cell-free DNA technology enables faster transitions to the clinic How to lower COGS through the use of dbDNARead more

day: Conference Day Two